AI-generated summary
The authors studied 13 adult cancer patients who had chemotherapy-induced oral mucositis and were treated with low level laser therapy at 830 nm over five days. They report a significant 67% decrease in average daily pain measured before and after each application. The study had no control group, so the authors note a possible placebo effect.
- Participants
- 13
- Who or what was studied
- Adult patients receiving oncology treatment who developed chemotherapy-induced oral mucositis
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The small number of patients meant no control group was included, so a potential placebo effect cannot be excluded.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
- Power
- 250 mW
- Total energy
- 35 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Oral mucositis, Placebo effect, Control group, Replication, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.